Michelle is a computational chemist in the Molecular Profiling and Drug Delivery at AbbVie, supporting drug development programs across the discovery–development continuum. Her work and research interests include prediction...
By Dr. Guanghui Zhu, Takeda Pharmaceuticals Particle engineering has emerged as a critical frontier in pharmaceutical process development, enabling control over drug formulation and delivery. By manipulating the size,...
Guanghui Zhu holds a PhD degree in Chemical Engineering from Georgia Tech. He currently works as a Senior Staff Engineer in the Synthetic Molecule Process Development group in Takeda,...
By Dr. Stephanie Kosnik, Boehringer Ingelheim Spherical Crystallization (agglomeration) is an emerging and versatile technique in the field of particle design, which transforms crystals into compact, free-flowing, and easily...
Stephanie received her Ph.D. in Chemistry from the University of Windsor (Ontario, Canada) with Prof. Charles L.B. Macdonald in 2017. There, she specialized in crystallography and organophosphorus transformations. After...
By Dr. David J. Lamberto, Merck The crystallization of an active pharmaceutical ingredient (API) from ethanol and water exhibited non-typical behavior relative to the formation of the desired three-dimensional...
David J. Lamberto received his bachelor’s degree in chemical engineering from the University of Arizona before pursuing his Ph.D. and master’s degrees in chemical engineering from Rutgers University. His...
Dr. Christopher Burcham is an AIChE Fellow and an Executive Director in the Synthetic Molecule Design and Development (SMDD) Department at Eli Lilly & Company. Chris leads the Crystallization and...
